These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3551545)

  • 1. Effects of different insulin administration modalities on vitamin D metabolism of insulin-dependent diabetic patients.
    Colette C; Monnier L; Arnal J; Selam JL; Mirouze J
    Adv Exp Med Biol; 1986; 208():501-8. PubMed ID: 3551545
    [No Abstract]   [Full Text] [Related]  

  • 2. Mineral metabolism in diabetes mellitus: changes accompanying treatment with a portable subcutaneous insulin infusion system.
    Gertner JM; Tamborlane WV; Horst RL; Sherwin RS; Felig P; Genel M
    J Clin Endocrinol Metab; 1980 May; 50(5):862-6. PubMed ID: 6246134
    [No Abstract]   [Full Text] [Related]  

  • 3. Insulin administration via a subcutaneous catheter. Effects on absorption.
    Käär ML; Mäenpää J; Knip M
    Diabetes Care; 1993 Oct; 16(10):1412-3. PubMed ID: 8269809
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of different insulin administration modalities on vitamin D metabolism of insulin-dependent diabetic patients.
    Colette C; Pares-Herbute N; Monnier L; Selam JL; Thomas N; Mirouze J
    Horm Metab Res; 1989 Jan; 21(1):37-41. PubMed ID: 2647606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Modalities of insulin therapy in decompensations of diabetes mellitus (results in 1977)].
    Beuscart R; Dewailly D; Bruy C; Lefebvre J; Linquette M
    Lille Med; 1980 Apr; 25(4):156-9. PubMed ID: 6771477
    [No Abstract]   [Full Text] [Related]  

  • 6. Alterations in vitamin D metabolites and minerals in diabetic pregnancy.
    Kuoppala T
    Gynecol Obstet Invest; 1988; 25(2):99-105. PubMed ID: 3371768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous versus subcutaneous insulin in the postoperative juvenile-onset diabetes mellitus (JODM) patient receiving a renal cadaver transplant.
    Fisher PB; Bennett WM; Norman D; Barry JM
    Proc Clin Dial Transplant Forum; 1980; 10():258-9. PubMed ID: 7050987
    [No Abstract]   [Full Text] [Related]  

  • 8. No change in apolipoprotein AI metabolism when subcutaneous insulin infusion is replaced by intraperitoneal insulin infusion in type 1 diabetic patients.
    Duvillard L; Florentin E; Baillot-Rudoni S; Lalanne-Mistrich ML; Brun-Pacaud A; Petit JM; Brun JM; Gambert P; Vergès B
    Atherosclerosis; 2007 Oct; 194(2):342-7. PubMed ID: 17141785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in circulating vitamin D metabolites in the young insulin-dependent diabetic.
    Frazer TE; White NH; Hough S; Santiago JV; McGee BR; Bryce G; Mallon J; Avioli LV
    J Clin Endocrinol Metab; 1981 Dec; 53(6):1154-9. PubMed ID: 7028772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin resistance caused by massive degradation of subcutaneous insulin.
    Paulsen EP; Courtney JW; Duckworth WC
    Diabetes; 1979 Jul; 28(7):640-5. PubMed ID: 109340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin therapy on the peritoneal route: effects on glucose control in experimental insulin dependent diabetes.
    Fischer U; Fritze K; Freyse EJ
    Exp Clin Endocrinol; 1990 Feb; 95(1):11-21. PubMed ID: 2185935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of glucose-controlled insulin infusion system for improvement of subcutaneous insulin regimen.
    Irsigler K; Kritz H; Kaspar L; Brändle J; Franetzki M
    Horm Metab Res Suppl; 1979; (8):134-40. PubMed ID: 395070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SHBG (sex hormone binding globulin) levels in insulin dependent diabetic patients according to the route of insulin administration.
    Lassmann-Vague V; Raccah D; Pugeat M; Bautrant D; Belicar P; Vague P
    Horm Metab Res; 1994 Sep; 26(9):436-7. PubMed ID: 7835829
    [No Abstract]   [Full Text] [Related]  

  • 14. [Subcutaneous insulin pumps].
    Bourgon C
    Soins; 1991 May; (548):29-30, 32-4. PubMed ID: 1853235
    [No Abstract]   [Full Text] [Related]  

  • 15. Continuous subcutaneous insulin infusion versus multiple daily injections of insulin: economic comparison in adult and adolescent type 1 diabetes mellitus in Australia.
    Cohen N; Minshall ME; Sharon-Nash L; Zakrzewska K; Valentine WJ; Palmer AJ
    Pharmacoeconomics; 2007; 25(10):881-97. PubMed ID: 17887808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Efficacy of continuous administration of insulin by subcutaneous route in the treatment of insulin-dependent diabetes mellitus].
    Dupré J
    Journ Annu Diabetol Hotel Dieu; 1982; ():221-35. PubMed ID: 7047839
    [No Abstract]   [Full Text] [Related]  

  • 17. Immediate-type human insulin allergy successfully treated by continuous subcutaneous insulin infusion.
    Nagai T; Nagai Y; Tomizawa T; Mori M
    Intern Med; 1997 Aug; 36(8):575-8. PubMed ID: 9260776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraperitoneal insulin affects insulin-like growth factor binding protein-1 in a well-controlled type I diabetic patient.
    Hopkins KD; Russell-Jones DL; Lehmann ED; Wheeler MJ; Sönksen PH
    Diabetes Care; 1993 Oct; 16(10):1404-5. PubMed ID: 7505735
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of 24-hour insulin requirements in IDDM patients during control by an artificial betacell and during conventional therapy.
    Christiansen JS; Svendsen PA; Mathiesen E; Rubin P; Deckert T
    Horm Metab Res; 1981 Oct; 13(10):537-41. PubMed ID: 7028586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Letter: Insulin dosage for diabetic keto-acidosis in children.
    Bonnici F
    S Afr Med J; 1976 Feb; 50(6):159. PubMed ID: 816014
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.